SEC Form 4 · accession 0001209191-17-008456
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jana Joustra Davis
Officer — SVP - Corporate Affairs
Period of report
Feb 3, 2017
Accepted (ET)
Feb 7, 2017 · 7:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 3, 2017 | M | 30,000 | $22.95 | A | 103,844 | D | |
| Common Stock | Feb 3, 2017 | F | 17,405 | $83.80 | D | 86,439 | D | |
| Common StockF1 | Feb 3, 2017 | S | 13,784 | $82.7905 | D | 72,655 | D | |
| Common Stock | holding | — | — | — | 51,950 | I | By GRAT (Spouse, Trustee) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $22.95 | Feb 3, 2017 | M | 30,000 | D | — | Feb 8, 2022 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.73 to $82.81, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The stock appreciation right vested in four equal annual installments beginning on February 8, 2013.